Bryan Veeren
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
-
- Neurological Disease Mechanisms and Treatments
Papers in
-
- Zebrafish Biomedical Research Applications 6
- Co-authors
- Olivier Meilhac (20 shared papers)Nicolas Diotel (12 shared papers)Philippe Rondeau (11 shared papers)Marie‐Paule Gonthier (7 shared papers)Matthieu Bringart (10 shared papers)Jessica Patché (4 shared papers)C. David (4 shared papers)Jean‐Loup Bascands (7 shared papers)
In The Last Decade
Bryan Veeren
20 papers receiving 372 citations
Peers
Comparison fields: 5 of 73
- Clinical Biochemistry 41
- Neurology 41
- Biochemistry 28
- Infectious Diseases 73
- Endocrinology, Diabetes and Metabolism 49
Countries citing papers authored by Bryan Veeren
This map shows the geographic impact of Bryan Veeren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Veeren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Veeren more than expected).
Fields of papers citing papers by Bryan Veeren
This network shows the impact of papers produced by Bryan Veeren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Veeren. The network helps show where Bryan Veeren may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Veeren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 76 | |
| 2 | 2019 | 43 | |
| 3 | 2021 | 34 | |
| 4 | 2020 | 30 | |
| 5 | 2022 | 28 | |
| 6 | 2022 | 22 | |
| 7 | 2020 | 22 | |
| 8 | 2023 | 22 | |
| 9 | 2020 | 15 | |
| 10 | 2020 | 15 | |
| 11 | 2021 | 14 | |
| 12 | 2022 | 13 | |
| 13 | 2019 | 11 | |
| 14 | 2022 | 9 | |
| 15 | 2023 | 7 | |
| 16 | 2022 | 6 | |
| 17 | 2022 | 4 | |
| 18 | 2025 | 2 | |
| 19 | 2021 | 2 | |
| 20 | 2025 | 2 |
About Bryan Veeren
Bryan Veeren is a scholar working on Molecular Biology, Cell Biology, Surgery, Clinical Biochemistry and Neurology, having authored 21 papers that have together received 377 indexed citations. Recurring topics across this work include Zebrafish Biomedical Research Applications (6 papers), Advanced Glycation End Products research (4 papers), Lipoproteins and Cardiovascular Health (4 papers), Neurological Disease Mechanisms and Treatments (3 papers), Phytochemicals and Antioxidant Activities (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Natural Antidiabetic Agents Studies (2 papers) and Biological and pharmacological studies of plants (2 papers). The work is most often cited by research in Clinical Biochemistry (41 citations), Neurology (41 citations), Biochemistry (28 citations), Infectious Diseases (73 citations) and Endocrinology, Diabetes and Metabolism (49 citations). Bryan Veeren has collaborated with scholars based in France, Réunion and Spain. Frequent co-authors include Olivier Meilhac, Nicolas Diotel, Philippe Rondeau, Marie‐Paule Gonthier, Matthieu Bringart, Jessica Patché, C. David, Jean‐Loup Bascands, Sébastien Tanaka and Philippe Montravers. Their work appears in journals such as Antioxidants, Scientific Reports, Biomedicines, International Journal of Molecular Sciences and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.